title: [Management of NSAIDs and low-dose-aspirin-induced ulcer in patients with cerebral infarction].
abstract: Use of low-dose aspirin (LDA) is increasing with guideline recommendation for stroke prevention. The risk of gastrointestinal symptoms and bleeding with aspirin is dose-dependent, but still increases even at low doses. The principal treatment for NSAIDs-induced ulcer is discontinuation of NSAIDs use. However, discontinuation of LDA administration in stroke patients can increase the risk of stroke recurrence. Therefore, use of LDA cannot easily be discontinued. In patients who experience gastric intolerance to aspirin, options are to reduce the dose of aspirin to the minimum effective dose; to change to dispersable or enteric-coated preparations; to add concomitant gastro-protective drugs such as antacids, misoprostol, proton pump inhibitors, or H2-receptor antagonists; or to change to another antithrombotic agent: clopidogrel, cilostazol or warfarin if appropriate.
authors.affiliation: Department of Neurology, Tokyo Women's Medical University.
authors.forename: Yumi
authors.initials: Y
authors.lastname: Kimura
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Uchiyama
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D002544:Cerebral Infarction / Q000188:drug therapy*; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin